Oct. 2014 – Present
Senior Director and Head, Breast Surgical Oncology,
Max Institute of Cancer Care, Max Super-speciality Hospital, Patparganj, Vaishali, Noida

Dr Geeta is presently heading the Breast Surgical Oncology Services at Max Institute of Cancer Care. Max Institute of Cancer Care is one of the few centres in Delhi offering exclusive and comprehensive breast care services in the form of screening, genetic counselling, surgery for both benign and malignant breast disease and exclusive medical oncology and radiation oncology services, complemented extremely well by dedicated breast radiology and pathology services. She is engaged in the entire gambit of surgeries for breast cancer, including mastectomies, breast conservation surgeries, axillary dissections, sentinel lymph node biopsy, Type I and II oncoplastic surgeries, surgeries for impalpable lesions etc.

A dedicated Breast Tumour Board to address specific areas of concern in each patient of breast cancer is conducted once every week. During the course of treatment, breast cancer patients are invited to attend Breast Support Group meetings once a month in an attempt to address their problems and to get them to interact with other ladies who have lived through or are currently going through the same experience. Psychological counselling, Physiotherapy and Diet advice are an integral part of this program.

• MBBS Internship – LHMC, New Delhi (1993)
• Houseman-ship – LHMC, New Delhi (1993)
• MS (General Surgery) MAMC – New Delhi, Delhi (1997)
• Senior Resident MAMC – New Delhi (2000)
• Senior Registrar – Indraprastha Apollo Hospitals, New Delhi (2002)
• Junior Consultant – Indraprastha Apollo Hospitals, New Delhi (2003)
• Clinical Research Fellow, Breast Unit – Royal Marsden Hospital, London, UK (2004)
• Consultant – Rajiv Gandhi Cancer Institute, New Delhi (2004-09)
• Senior Consultant, Breast Surgical Oncology – Max Superspeciality Hospital (2009-14)

• Vice President, Oncology Forum
• Ex Secretary – Oncology Forum
• Executive member, IASO
• Founder Member and Hony Secretary – Delhi Breast Oncology Group
• Past Executive Member – Association of Breast Surgeons of India
• Past Executive Member – Indian Society of Oncology
• Indian Association of Surgical Oncologists
• Association of surgeons of India

1. Bliss Foundation (Hyperlink with: https://www.blissfoundation.org.in )

With its motto of “Beautifying Lives and Strengthening Souls”, the organization is committed to enhancing the quality of lives of all those who are afflicted by cancer.

2. DELHI BREAST ONCOLOGY GROUP (DBOG)

Founder secretary of the DBOG, the first subspeciality group of the Oncology Forum. Held the first CME at Max Hospital, Patparganj on January 3^rd 2015.

• Lead, National Steering Committee, India- EUBREAST sponsored multicentric, AXSANA Trial
• Program Director, Breast Surgical Oncology Fellowship at Max Hospital, Patparganj and Vaishali
• Indian Faculty, MCh Oncoplasty, University of East Anglia
• Weekly dedicated breast tumour board meetings with Breast cancer centric Surgical, Medical and Radiation oncologists, breast radiologist, breast pathologist, geneticist and psychologist
• Monthly Breast Oncology Research Forum meetings to initiate research, discuss projects and encourage publication amongst like-minded peer.
• Principal Investigator, Hospital based Cancer Registry Program, Max Hospital Patparganj
• Annual October Support Group meeting over the last 5 years.
• Monthly Breast Support Group meetings – To address patient specific issues and encouraging much needed support and encouragement among patients.

• Pink illumination of monuments (Qutub Minar, Akshardham Temple, Safdarjung Tomb, Times of India Building, the Max Hospitals etc) in October 2012
• Pink Dandiya – Carnival and dance on 18th October 2014 with patients and their relatives
• Fashion Show – Ramp walk with 20 survivors on 22nd March 2015 in collaboration with Max India Foundation and Australian High Commission.
• Pink Carnival with more than 600 people, mainly breast cancer survivors, in attendance on 25th October 2015
• Pink Raahgiri – the largest ever breast cancer awareness program with 6000 people attending it, held on 16th October 2016 at Connaught Place New Delhi
• ‘Touch Feel and Do’ Breast cancer awareness workshops amongst the general public

• Lead, National Steering Committee, India- EUBREAST sponsored multicentric trial, AXSANA
• Currently involved as Principal Investigator in another multicentre trial with Tata Memorial Hospital, titled, ‘A Phase II Randomised Controlled Study of Inj Proluton (Hydroxyprogesterone caproate) as single dose preoperative therapy in patients with high-risk operable breast cancer.
• Principal Investigator of the Hospital Based Cancer Registry and Patterns of Care data linked to the National Cancer Registry Program since March 2018.
• Involved as Co-investigator in a Radiology thesis at Max Hospital, Patparganj comparing the findings of MR mammogram with histopathology in Carcinoma breast
• Involved as Co-investigator in two other Multi-Centre studies, one is a Phase 4 trial of Trastuzumab biosimilar in the adjuvant treatment of patients with early breast cancer and another examining the combination of Ribociclib with Letrozole.
• Involved as Principal Investigator in a multi-centre trial spearheaded by Tata Memorial Hospital, titled, ’Randomized controlled trial to assess blockade of voltage gated sodium channels during surgery in operable breast cancer (VGSC Study).
• Co-investigator in a thesis titled, ‘A Study of Correlation of MR mammogram and histopathological findings in Carcinoma breast, in the Department of Surgical Oncology at Max Saket, 2014-2015
• Co-investigator in thesis done by anaesthesia DNB students at Saket and Patparganj.

• Women of Influence Award 2019 presented by Garnet and Gold for exemplary work in the field of Health-care on 8th March 2019, International Women’s Day
• Second prize for poster presentation at the Patient Outcomes Conference in February 2019
• Max Healthcare CEO’s Award in recognition of exemplary display of Max’s core values- Sevabhav, Credibility and Excellence-on 7th December 2018
• First prize for Case Discussion Competition in the 3rd Indo UK Breast Oncoplastic, Masterclass/Conference in August 2016
• First prize for Case Discussion Competition in the 2nd Indo UK Breast Oncoplastic, Masterclass /Conference in February 2015
• Poster presentation at Rajiv Gandhi Cancer Institute, New Delhi – Awarded the first prize in 2002
• Annie McKenzie award: Final year of MBBS for contributing maximally to the corporate life of the college, 1992 Delhi Medical Association Annual Debate 1989 – Awarded the first prize
• National Science Seminar, 1984: Adjudged 2nd in the event and awarded a scholarship for 2 years

1. False Negative Rate of Sentinel Lymph Node Biopsy on Intraoperative Frozen Section in Early Breast Cancer Patients: An Institutional Experience. Gupta, S., Kadayaprath, G., Ambastha, R. et al. Indian J Surg Oncol (2021). https://doi.org/10.1007/s13193-021-01458-7
2. Bilateral Risk-Reducing Prophylactic Mastectomies in an Unaffected BRCA1 Carrier Using Dermal Sling and Implant. S Gupta, G Kadayaprath, N Gupta, V Barthwal – Indian Journal of Surgical Oncology, 2021
3. Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status … Maggie Banys-Paluchowski, Maria Luisa Gasparri, …Kadayaprath G… Cancers 13 (7), 1565
4. Internal audit of an Indian breast oncosurgery unit using EUSOMA guidelines.S Gupta, N Gupta, G Kadayaprath.European Journal of Cancer 138, S38, 2020
5. Application of ACOSOG Z0011 patient selection criteria to an Indian breast cancer cohort undergoing sentinel lymph node biopsy. AK Goel, V Zamre, G Kadayaprath, N Gupta, V Chaudhary, N Guthula, R Tandon, N Kapoor 2020/10/1 European Journal of Cancer
6. Sentinel lymph node biopsy in early breast cancer: Experience from a tertiary care facility in India. AK Goel, V Zamre, G Kadayaprath, N Gupta, V Chaudhary, N Guthula, R Tandon, N Kapoor – European Journal of Cancer, 2020
7. Use of sentinel lymph node biopsy and early physiotherapy to reduce incidence of lymphedema after breast cancer surgery: an institutional experience.S Gupta, N Gupta, G Kadayaprath, S Neha – Indian Journal of Surgical OPUBncology, 2020
8. Sentinel Lymph Node Biopsy in a Male Breast Cancer: an Underutilized Procedure in India. S Gupta, G Kadayaprath, N Gupta – Indian Journal of Surgery, 2020
9. Use of sentinel lymph node biopsy and early physiotherapy to reduce incidence of lymphedema after breast cancer surgery: an institutional experience. Gupta S, Gupta N, Kadayaprath G. Accepted for publication in IJSO in December 2019
10. SVC obstruction secondary to indwelling central venous catheter- A case report. Kadayaprath G, Gupta N, Chaturvedi HK, Agarwal M. Ann.Int. Med. Den. Res. 2018; (4(3):SO03- SO04
11. Diagnostic Accuracy of MRI in breast cancer-A Study of 156 cases. Bansal R, Gupta N, Kadayaprath G, Chaturvedi HK, Agarwal M. Ann.Int. Med. Den. Res. 2018; (4(3): SO05- SO11
12. Angiosarcoma- A Case Report. Saxena T, Gupta N, Kadayaprath G, Chaturvedi HK, Agarwal M. Ann.Int. Med. Den. Res. 2018; (4(3): SO01- SO02
13. Biospectroscopic analysis of breast cancer tissue: Probing infrared signatures to comprehend biochemical alterations. Mehrotra R, Tyagi G, Charak S, Ray B, Kadayaprath G et al. Journal of Biomolecular Structure and Dynamics, 2017
14. Long term quality-of life-assessment following one- stage immediate breast reconstruction using bio-dimensional expander implants: The patients’ perspective. Gui GPH, Kadayaprath G, Tan S et al. Plast Reconstr Surg. 2008 Jan; 121(1): 17-24.
15. Clinical outcome and service implications of screening women at an increased breast cancer risk from family history.Gui GH,
16. Kadayaprath G, Darhouse N, Self J, Ward Ann, A’Hern R, Eeles R. Eur J Surg Oncol.2006 Sep; 32(7):719-724
17. Five year follow- up of one stage implant assisted immediate breast reconstruction using McGhan 150 biodimensional anatomic expander implant . Kadayaprath G, Tan SM, Faliakou E C, Gui G H. ( Abstract) Eur J Surg Oncol.2005;31:1053.
18. Evaluation of outcome after immediate breast reconstruction: prospective comparison of four methods. Gui GPH, Kadayaprath G, Tan S et al. Plast Reconstr Surg. 2005 Jun; 115(7): 1916-26.
19. Prospective comparison of measurement outcome tools after immediate breast reconstruction: does perception match observation?
20. Kadayaprath, G.; Ward, A.; A’Hern, R.; Gui, G. P. H. (Abstract) B J Surg. 2004 May; Vol 91, Supplement 1, 39 Siting of drains after surgery. H.K. Chaturvedi, K. Geeta. Journal of Surgical Oncology 2003 May; 83(1): 51
21. Management of locally advanced breast carcinoma – H.K. Chaturvedi, K. Geeta – Proceedings of Surgery Update, 2001, New Delhi, India
22. Performance assessment scores in cancer patients – Dr. R.K. Jindal, Dr. K.Geeta – Proceedings of Surgery Update 1999, N.Delhi, India.
23. Ulcerative Colitis – Dr. K. Geeta, Dr. V.K. Malik – March 1999 edition of Mediquest, India.
24. Thesis titled “Comparative evaluation of the results of Anal Dilatation, Posterior Internal Sphincterotomy & Subcutaneous Lateral Internal Sphincterotomy in the treatment of Anal Fissure” – Accepted by the Delhi University in 1996. Results show that subcutaneous lateral internal, sphincterotomy is the treatment of choice for anal fissure.

Dr Geeta Kadayaprath has been fortunate to be associated with one of the finest centres in cancer care during her fellowship at the Royal Marsden Hospital, London, UK. She has gained a lot from her experiences at Rajiv Gandhi Cancer Institute and now at Max Institute of Cancer Care and continues to evolve with each passing day. She has been associated as faculty with the Indo-UK Oncoplasty Masterclass at Pune over the last 4 years and has had the opportunity to attend the Oncoplasty Masterclass offered by the European Institute of Oncology, Paris under the tutelage of Dr Krishna Clough.

Dr Geeta would like to dedicate herself to the delivery of comprehensive services for breast cancer patients in a truly multi-disciplinary manner. She would love to engage in teaching and imparting whatever skills she has gained from her mentors over the years to the young surgeons wanting take up breast cancer surgery as their career choice.

She would also like to involve in breast cancer research projects aimed at reducing the morbidity and mortality in breast cancer and further international collaboration in such efforts.